JETBLUE AIRWAYS CORP (JBLU)

US4771431016 - Common Stock

7.44  +0.15 (+2.06%)

After market: 7.5 +0.06 (+0.81%)

Fundamental Rating

2

Overall JBLU gets a fundamental rating of 2 out of 10. We evaluated JBLU against 23 industry peers in the Passenger Airlines industry. JBLU has a bad profitability rating. Also its financial health evaluation is rather negative. JBLU is valued expensive and it does not seem to be growing.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

JBLU had negative earnings in the past year.
In the past year JBLU had a positive cash flow from operations.
In the past 5 years JBLU reported 4 times negative net income.
Of the past 5 years JBLU 4 years had a positive operating cash flow.

1.2 Ratios

JBLU has a Return On Assets of -5.14%. This is comparable to the rest of the industry: JBLU outperforms 43.48% of its industry peers.
JBLU has a Return On Equity of -32.30%. This is comparable to the rest of the industry: JBLU outperforms 43.48% of its industry peers.
Industry RankSector Rank
ROA -5.14%
ROE -32.3%
ROIC N/A
ROA(3y)-2.12%
ROA(5y)-2.33%
ROE(3y)-8.06%
ROE(5y)-9.32%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 64.75%, JBLU is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
JBLU's Gross Margin has been stable in the last couple of years.
JBLU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.29%

More info and screens

3

2. Health

2.1 Basic Checks

JBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JBLU has been increased compared to 1 year ago.
The number of shares outstanding for JBLU has been increased compared to 5 years ago.
The debt/assets ratio for JBLU is higher compared to a year ago.

2.2 Solvency

JBLU has an Altman-Z score of 0.81. This is a bad value and indicates that JBLU is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.81, JBLU perfoms like the industry average, outperforming 43.48% of the companies in the same industry.
A Debt/Equity ratio of 2.98 is on the high side and indicates that JBLU has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.98, JBLU is in line with its industry, outperforming 43.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.98
Debt/FCF N/A
Altman-Z 0.81
ROIC/WACCN/A
WACC6.18%

2.3 Liquidity

A Current Ratio of 1.21 indicates that JBLU should not have too much problems paying its short term obligations.
The Current ratio of JBLU (1.21) is better than 91.30% of its industry peers.
A Quick Ratio of 1.18 indicates that JBLU should not have too much problems paying its short term obligations.
JBLU has a better Quick ratio (1.18) than 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.18

More info and screens

3

3. Growth

3.1 Past

JBLU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1066.67%.
The Revenue has decreased by -3.90% in the past year.
The Revenue has been growing slightly by 4.66% on average over the past years.
EPS 1Y (TTM)-1066.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.97%
Revenue 1Y (TTM)-3.9%
Revenue growth 3Y48.15%
Revenue growth 5Y4.66%
Sales Q2Q%0.51%

3.2 Future

JBLU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.35% yearly.
JBLU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.19% yearly.
EPS Next Y-91.17%
EPS Next 2Y-16.03%
EPS Next 3Y25.57%
EPS Next 5Y31.35%
Revenue Next Year-3.37%
Revenue Next 2Y0.72%
Revenue Next 3Y-0.12%
Revenue Next 5Y4.19%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JBLU. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JBLU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

JBLU's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.82

4.3 Compensation for Growth

A more expensive valuation may be justified as JBLU's earnings are expected to grow with 25.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.03%
EPS Next 3Y25.57%

More info and screens

0

5. Dividend

5.1 Amount

JBLU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JETBLUE AIRWAYS CORP

NASDAQ:JBLU (12/20/2024, 8:19:45 PM)

After market: 7.5 +0.06 (+0.81%)

7.44

+0.15 (+2.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)01-28 2025-01-28/amc
Inst Owners82.16%
Inst Owner Change9.69%
Ins Owners10.27%
Ins Owner Change2.58%
Market Cap2.58B
Analysts51.82
Price Target6.4 (-13.98%)
Short Float %16.73%
Short Ratio2.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)103.75%
Min EPS beat(2)37.94%
Max EPS beat(2)169.56%
EPS beat(4)4
Avg EPS beat(4)64.76%
Min EPS beat(4)18.47%
Max EPS beat(4)169.56%
EPS beat(8)6
Avg EPS beat(8)28.04%
EPS beat(12)8
Avg EPS beat(12)-6.97%
EPS beat(16)12
Avg EPS beat(16)-0.68%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-0.88%
Max Revenue beat(2)-0.74%
Revenue beat(4)0
Avg Revenue beat(4)-0.91%
Min Revenue beat(4)-1.78%
Max Revenue beat(4)-0.26%
Revenue beat(8)0
Avg Revenue beat(8)-1.47%
Revenue beat(12)0
Avg Revenue beat(12)-1.65%
Revenue beat(16)4
Avg Revenue beat(16)-0.61%
PT rev (1m)0.43%
PT rev (3m)10.47%
EPS NQ rev (1m)-0.31%
EPS NQ rev (3m)-195.18%
EPS NY rev (1m)2.22%
EPS NY rev (3m)17.39%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-6.6%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)0.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF 34.41
P/B 0.98
P/tB 1.15
EV/EBITDA 10.82
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.63
Fwd EYN/A
FCF(TTM)-4.5
FCFYN/A
OCF(TTM)0.22
OCFY2.91%
SpS26.89
BVpS7.62
TBVpS6.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.14%
ROE -32.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.75%
FCFM N/A
ROA(3y)-2.12%
ROA(5y)-2.33%
ROE(3y)-8.06%
ROE(5y)-9.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.29%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 2.98
Debt/FCF N/A
Debt/EBITDA 15.8
Cap/Depr 253.1%
Cap/Sales 17.53%
Interest Coverage N/A
Cash Conversion 15.06%
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.18
Altman-Z 0.81
F-Score4
WACC6.18%
ROIC/WACCN/A
Cap/Depr(3y)178.75%
Cap/Depr(5y)180.86%
Cap/Sales(3y)13.03%
Cap/Sales(5y)16.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1066.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.97%
EPS Next Y-91.17%
EPS Next 2Y-16.03%
EPS Next 3Y25.57%
EPS Next 5Y31.35%
Revenue 1Y (TTM)-3.9%
Revenue growth 3Y48.15%
Revenue growth 5Y4.66%
Sales Q2Q%0.51%
Revenue Next Year-3.37%
Revenue Next 2Y0.72%
Revenue Next 3Y-0.12%
Revenue Next 5Y4.19%
EBIT growth 1Y-240.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year484.3%
EBIT Next 3Y124.87%
EBIT Next 5Y93.75%
FCF growth 1Y-167.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.94%
OCF growth 3YN/A
OCF growth 5Y-19.73%